VANCOUVER, British Columbia and SAN DIEGO, June 4, 2019 –  Phoenix Molecular Designs (PhoenixMD), a privately-held biotechnology company des...

Novartis announced statistically significant overall survival (OS) results for Kisqali in combination with endocrine therapy[1]. The Phase 3 MONALEESA-7 trial evalu...

Shares of Maryland-based MacroGenics fell by nearly 20% Tuesday after its experimental drug for advanced breast cancer showed only a "modest" impact on delaying tumo...

PHILADELPHIA — The Food and Drug Administration is "open for business" in considering real-world evidence to clear expanded uses of new cancer drugs, acting agency h...

The series C cash will also fund a phase 1 trial in idiopathic pulmonary fibrosis. (Pixabay) Lung Therapeutics has raised a $36 million series C round to take a ...

Amgen (NASDAQ: AMGN), along with leading community oncology networks, today announced the launch of Amgen Community Oncology Research Collaborators (ACORC), a new i...